PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1050
https://www.valueinhealthjournal.com/article/S1098-3015(21)01267-5/fulltext
Title :
PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01267-5&doi=10.1016/j.jval.2021.04.1050
First page :
Section Title :
Open access? :
No
Section Order :
10542